ABAX 55.02 Abaxis Inc $ABAX Hit a 52 week high of 55.22

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2014 at 10:03 AM

ABAX 55.02 Abaxis Inc $ABAX Hit a 52 week high of 55.22 Closing the day 09:45 at 55.02 +0.22 +0.40% With a day low of 54.38 and a total volume of 11,871.

ABAX Recent Posts: http://investorshangout.com/Abaxis-ABAX-53195/

ABAX Abaxis Inc Recent Headline News

Strength Seen in Cerus (CERS): Stock Gains 5.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 8:25AM CST
Cerus (CERS) was a big mover last session, with shares rising nearly 6% on the day.
CERS: 4.43 (+0.02), ABAX: 55.23 (+0.43), GWPH: 76.09 (+0.46), OSUR: 8.89 (+0.12)

Abaxis, Inc. to Present at the Canaccord Genuity Medical Technology & Diagnostic Forum
PR Newswire - Fri Nov 14, 7:00AM CST
Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood instrumentation and consumables to the medical, research and veterinary markets, announced today that Don Wood, Chief Operating Officer, will present at the Canaccord Genuity 2014 Medical Technology & Diagnostics Forum on Thursday, November 20, 2014 at 8:00 a.m. ET. The conference will be held at The Westin Grand Central Hotel in New York City.
ABAX: 55.23 (+0.43)

Allscripts Healthcare and CHI Sign Hosting Solution Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 12:40PM CST
By utilizing Allscripts Healthcare Solutions, Inc. (MDRX) Hosting Solution, Catholic Health Initiatives expects improved system availability, reduced IT infrastructure expenditures as well as enhanced end user performance.
GWPH: 76.09 (+0.46), ABAX: 55.23 (+0.43), MDRX: 12.51 (+0.07), MRGE: 3.28 (+0.04)

3 Stocks Going Ex-Dividend Tomorrow: ERH, PHT, ABAX
at The Street - Wed Nov 12, 9:52AM CST
ERH PHT ABAX are going ex-dividend tomorrow, Thursday, November 13, 2014
PHT: 17.58 (-0.04), ERH: 13.34 (+0.14), ABAX: 55.23 (+0.43)

Meridian Bioscience (VIVO) Misses Q4 Earnings, Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 9:20AM CST
Meridian Bioscience Inc. (VIVO) reported fourth-quarter fiscal 2014 earnings of 20 cents per share, which missed the Zacks Consensus Estimate by a couple of cents
BSX: 13.38 (+0.02), VIVO: 16.20 (+0.01), ABAX: 55.23 (+0.43), OSUR: 8.89 (+0.12)

INSYS Therapeutics (INSY) in Focus: Stock Rises 12% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 7:44AM CST
INSYS Therapeutics, Inc. (INSY) was a big mover last session, as the company saw its shares surge 12%
ICUI: 86.13 (+0.42), INSY: 38.77 (+0.20), ABAX: 55.23 (+0.43), GWPH: 76.09 (+0.46)

Omeros (OMER) Catches Eye: Stock Jumps 8.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 7:30AM CST
Omeros Corporation (OMER) was a big mover last session, as the company saw its shares rise almost 9% on the day.
ABAX: 55.23 (+0.43), GWPH: 76.09 (+0.46), OSUR: 8.89 (+0.12), OMER: 19.30 (+0.32)

Abaxis, Inc. to Present at the Stifel 2014 Healthcare Conference
PR Newswire - Wed Nov 12, 7:00AM CST
Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood instrumentation and consumables to the medical, research and veterinary markets, announced today that Don Wood, Chief Operating Officer, will present at the Stifel 2014 Healthcare Conference on Tuesday, November 18, 2014 at 9:45 a.m. ET. The conference will be held at the New York Palace Hotel in New York City.
ABAX: 55.23 (+0.43)

Omnicell Reports Mixed Q3, Positive on Surgichem Buyout - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 2:00PM CST
On Nov 6, 2014, we issued an updated research report on Omnicell Inc. (OMCL).
BSX: 13.38 (+0.02), ICUI: 86.13 (+0.42), ABAX: 55.23 (+0.43), OMCL: 32.59 (+0.33)

Boston Scientific Shows Strength on Core Market Stabilization - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 1:50PM CST
On Nov 7, 2014, we issued an updated research report on leading medical devices company Boston Scientific Corporation (BSX).
BSX: 13.38 (+0.02), ICUI: 86.13 (+0.42), BCR: 164.40 (+0.36), ABAX: 55.23 (+0.43)

Ex-Dividend Reminder: Abaxis, Chemed and AmerisourceBergen
DividendChannel.com - Tue Nov 11, 9:50AM CST
Looking at the universe of stocks we cover at Dividend Channel, on 11/13/14, Abaxis, Inc. , Chemed Corp , and AmerisourceBergen Corp.
ABAX: 55.23 (+0.43)

Eagle Pharmaceuticals (EGRX) Jumps: Stock Gains 8.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 8:46AM CST
Eagle Pharmaceuticals (EGRX) was a big mover last session, with shares rising over 8% on the day.
ICUI: 86.13 (+0.42), ABAX: 55.23 (+0.43), GWPH: 76.09 (+0.46), EGRX: 12.70 (+0.04)

Walgreens Hits the Rock with Court's Ruling on CFO Lawsuit - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 2:30PM CST
The controversy surrounding an inflated fiscal 2016 earnings forecast continues for leading drugstore chain Walgreen Co. (WAG).
BSX: 13.38 (+0.02), ICUI: 86.13 (+0.42), ABAX: 55.23 (+0.43), WAG: 66.80 (-0.13)

Emergent BioSolutions Beats on Q3 Earnings, Guidance Up - Analyst Blog
Lopamudra Bhattacharya - Zacks Investment Research - Mon Nov 10, 11:30AM CST
Emergent BioSolutions reported third quarter earnings of 67 cents per share.
AGN: 211.86 (+13.21), EBS: 24.18 (-0.04), ABAX: 55.23 (+0.43), ABBV: 64.95 (+0.95)

Meridian Bioscience (VIVO) Falls: Stock Goes Down 5.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 7:55AM CST
Meridian Bioscience saw a big move last session, as the company’s shares fell by nearly 6% which continued the recent downtrend
VIVO: 16.20 (+0.01), ABAX: 55.23 (+0.43), GWPH: 76.09 (+0.46), OSUR: 8.89 (+0.12)

BioScrip (BIOS) Q3 Loss Wider than Expected, Revenues Top - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 2:10PM CST
BioScrip, Inc. (BIOS) recently declared its third-quarter 2014 results.
BSX: 13.38 (+0.02), ICUI: 86.13 (+0.42), ABAX: 55.23 (+0.43), BIOS: 5.77 (-0.14)

Allscripts Healthcare Q3 Earnings, Revenues Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 12:30PM CST
Allscripts Healthcare Solutions, Inc. (MDRX) posted adjusted earnings of 2 cents per share in the third quarter of 2014 which missed the Zacks Consensus Estimate by 3 cents.
GWPH: 76.09 (+0.46), ABAX: 55.23 (+0.43), MDRX: 12.51 (+0.07), MRGE: 3.28 (+0.04)

Omnicell Earnings Hit by High Tax, User Addition Aids Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 11:27AM CST
On Nov 7, 2014, we issued an updated research report on Omnicell Inc. (OMCL).
BSX: 13.38 (+0.02), ICUI: 86.13 (+0.42), ABAX: 55.23 (+0.43), OMCL: 32.59 (+0.33)

SurModics Beats on Q4 Earnings, Issues Fiscal 2015 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:10AM CST
SurModics, Inc.???s fourth-quarter fiscal 2014 adjusted earnings of 26 cents per share beat the Zacks Consensus Estimate by a penny.
AGN: 211.86 (+13.21), SRDX: 21.74 (+0.28), ABAX: 55.23 (+0.43), ABBV: 64.95 (+0.95)

Wright Medical Posts Wider Q3 Loss; Lowers '14 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:50AM CST
Following the earnings release, shares of Wright Medical Group Inc. (WMGI) dropped nearly 5.7% to close at $28.44 yesterday.
BSX: 13.38 (+0.02), WMGI: 28.29 (+0.21), GWPH: 76.09 (+0.46), ABAX: 55.23 (+0.43)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DCM Services Teams with AKUVO to Boost Estate Recoveries

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Americas Cardroom's Poker Series Hits $7.2M Haul

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Intus Bio Secures $2.7M for Colorectal Cancer Test

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Veteran Marketer Joins The Wisory's Advisory Board

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

BusyBee AI Revolutionizes Classroom Feedback Efficiency

Grading Overhaul: BusyBee's Role in Education Here's a twist for the history books: Agilix Labs' BusyBee, a slick AI assistant built right into the Buzz platform on Amazon Bedrock, is kicking traditional grading methods to the curb. This little helper is grading close to a million K-12 student submissions every month, meticulously approved by real teachers. Quite the...

Modeling and Mental Health Join Forces for Wellness

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Moore Law Investigates Aardvark Therapeutics' Risks

Moore Law Launches Probe Into Aardvark Therapeutics Nobody likes stumbling across bad news over their morning coffee, but sometimes the market loves to keep you on your toes. Now it's Aardvark Therapeutics (NASDAQ: AARD) in the headlines, and not how they'd like. This time, Moore Law PLLC is rolling up its sleeves to dig into potential misconduct by the company's top...

Liberty Hill: 50 Years of Grassroots Revolution

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

High-Grade Copper Spurs Optimism for PolarX in Alaska

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...